The 5 Minute Urology Consult 3rd Ed.

CYSTOCELE

Alana M. Murphy, MD

BASICS

DESCRIPTION

• Cystocele is prolapse of the bladder into the vagina

• Also referred to as anterior compartment prolapse

EPIDEMIOLOGY

Incidence

11% lifetime risk of surgery for pelvic organ prolapse (POP) or urinary incontinence (UI) (1)

Prevalence

• Difficult to determine due to several factors:

– Data mostly reported in the context of surgical treatment

– Cystocele may be asymptomatic

– Diagnosis requires a vaginal exam

• POP quantification (POP-Q) distribution in an observational study of women 18–82 yr old seeking routine gynecologic care (2):

– POP-Q stage 0: 6.4%

– POP-Q stage 1: 43.3%

– POP-Q stage 2: 47.7%

– POP-Q stage 3: 2.6%

RISK FACTORS

• Increasing age

• Parity

• Vaginal delivery (nerve, muscle, and connective tissue damage)

– Instrumented vaginal delivery may be associated with a higher risk of POP compared to spontaneous vaginal delivery

• Race (3)

– Hispanic women have highest prevalence of POP

• Increased intra-abdominal pressure (obesity, chronic cough, constipation)

• Pelvic surgery (hysterectomy, radical cystectomy)

• Congenital connective tissue disorders (Ehlers–Danlos syndrome)

Genetics

• Connective tissue disorders, bladder exstrophy

• POP prevalence rates differ according to race suggesting a genetic component (3)

PATHOPHYSIOLOGY

• Weakening of supporting and suspending structures: Cardinal ligaments, uterosacral ligaments, endopelvic fascia, pubocervical fascia, levator ani muscles

• Defect location:

– Central: Attenuation of the pubocervical fascia in the midline

– Lateral: Disruption of lateral attachments of the endopelvic fascia to the arcus tendineus fascia pelvis (ATFP)

– Combined defects

ASSOCIATED CONDITIONS

• Multicompartment POP

– Always suspect concomitant apical prolapse in the setting of stage ≥3 cystocele

• Storage symptoms/signs: Stress UI, urinary urgency, urgency urinary incontinence (UI)

• Voiding symptoms/signs: Weak urinary stream, urinary hesitancy, elevated postvoid residual (PVR) urine, bladder outlet obstruction, urinary retention

GENERAL PREVENTION

• Reduction of modifiable risk factors

• Additional studies examining the role of prophylactic vaginal support at the time of pelvic surgery (eg, hysterectomy) are needed

DIAGNOSIS

HISTORY

• Symptoms/signs: Pelvic pressure, vaginal pressure, sensation of a vaginal bulge, stress/urgency/ overflow UI, obstructive voiding symptoms, recurrent urinary tract infections (UTIs)

• Previous pelvic/vaginal surgical procedures

• Hormonal status

• Obstetric history

• Comorbidities

PHYSICAL EXAM

• Assessment of POP should be performed during a Valsalva maneuver

• Leading edge of POP should be used for staging purposes

• Examining a patient in a standing position may help determine the maximum extent of POP

• Assessment of the anterior compartment should be performed with support of the apical and posterior compartment to ensure the elimination of potentially distracting apical and posterior POP

• Baden-Walker grading system:

– Grade 0: No POP

– Grade 1: Leading edge descends halfway to the hymen

– Grade 2: Leading edge descends to the hymen

– Grade 3: Leading edge descends halfway past the hymen

– Grade 4: Procidentia or vault eversion

• POP-Q staging system:

– POP described using 9 reference measurements, including 2 measurements specific to the anterior vaginal wall

Aa: Distal anterior vaginal wall

Ba: Proximal anterior vaginal wall

– Stage 0: No POP

– Stage 1: Leading edge is >1 cm above the hymen

– Stage 2: Leading edge is between 1 cm above and 1 cm below the hymen (-1, 0, +1)

– Stage 3: Leading edge is >1 cm below the hymen but less than total vaginal length – 2 cm (TVL – 2 cm)

– Stage 4: Leading edge is below hymen by more than TVL – 2 cm

DIAGNOSTIC TESTS & INTERPRETATION

Lab

• No lab testing is required for the diagnosis of a cystocele

• Urinalysis and urine culture as indicated

Imaging

• No imaging is required for the diagnosis or management of a cystocele

• A cystocele may inadvertently be detected on imaging studies, such as a cystogram

• Dynamic magnetic resonance imaging (MRI) with contrast:

– Examines pelvic structures in relation to one another during a Valsalva maneuver

– Aids in differentiation between a cystocele and an enterocele

– Aids in assessment of multicompartment POP

Diagnostic Procedures/Surgery

• Pelvic exam

– Employ standardized staging system (POP-Q or Baden-Walker)

• PVR assessment

• Urodynamics

– Only indicated to characterize associated storage and voiding symptoms/signs

Pathologic Findings

N/A

DIFFERENTIAL DIAGNOSIS

• Cystocele

• Enterocele

• Anterior vaginal wall masses: Urethral diverticulum, Skene gland cyst, epidermal inclusion cyst, leiomyoma, ectopic ureterocele, Bartholin duct cyst, Gartner duct cyst

TREATMENT

GENERAL MEASURES

• Observation

• Pelvic floor exercises (Kegel exercises) (4)[B]

• Vaginal pessary

• Surgical repair

MEDICATION

First Line

There are no data to support systemic or topical estrogen or other medications as a therapy for the treatment of cystocele.

Second Line

N/A

SURGERY/OTHER PROCEDURES

• Preoperative preparation:

– Optional hormone replacement with topical estrogen

• Perioperative factors:

– Single dose of preoperative antibiotics

– DVT prophylaxis with sequential compression devices

– Optional vaginal packing

– Optional temporary urethral catheterization

Consider in the setting of a multicompartment repair with or without an anti-incontinence procedure

• Transvaginal vs. transabdominal repair:

– Transvaginal repair:

Central defect repair: Plication of pubocervical fascia in the midline with horizontal mattress sutures

Lateral defect repair: Reattachment of the endopelvic fascia to the ATFP

Transvaginal mesh grafts provide a superior anatomic outcome but are associated with higher complication rates (5)[A]

– Transabdominal repair:

Only repair lateral defects

• Closure of the vagina (colpocleisis):

– Excellent option for geriatric women who no longer desire the ability to maintain sexual activity

• Perform a simultaneous repair of all POP defects and an anti-incontinence procedure for demonstrable stress UI

• Consider a prophylactic concomitant anti-incontinence procedure in patients with stage ≥3 cystocele and/or history of stress UI

ADDITIONAL TREATMENT

Radiation Therapy

N/A

Additional Therapies

• Observation:

– Appropriate if a patient is not symptomatic

• Pelvic floor exercises (Kegel exercises) (4)[B]

• Vaginal pessary:

– Good option for poor surgical candidates

– May be used as a temporary solution

– Risk of vaginal discharge, vaginal ulceration, vesicovaginal and rectovaginal fistula formation

Complementary & Alternative Therapies

N/A

ONGOING CARE

PROGNOSIS

• Recurrence rates as high as 30–70%

• Close to 30% of women will require reoperation for symptomatic POP (1)

COMPLICATIONS

• Bladder injury

• Ureteral injury/obstruction

• Bleeding

• Dyspareunia

de novo stress UI

• Recurrent cystocele

FOLLOW-UP

Patient Monitoring

Evaluation for recurrent POP should largely be based on symptoms or clinical signs (elevated PVR, urinary retention, recurrent UTIs)

Patient Resources

• American Urogynecologic Society. http://www.voicesforpfd.org/p/cm/ld/fid=6

• International Urogynecological Association. www.iuga.org/resource/resmgr/Brochures/eng_pop.pdf

REFERENCES

1. Olsen AL, Smith VJ, Bergstrom JO, et al. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89:501–506.

2. Swift SE. The distribution of pelvic organ support in a population of female subjects seen for routine gynecologic healthcare. Am J Obstet Gynecol. 2000;183:277–285.

3. Nygaard I, Barber MD, Burgio KL, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008;300:1311–1316.

4. Braekken IH, Majida M, Engh ME, et al. Can pelvic floor muscle training reverse pelvic organ prolapse and reduce prolapse symptoms? An assessor-blinded, randomized, controlled trial. Am J Obstet Gynecol. 2010;203:e1–e7.

5. Altman D, Väyrynen T, Engh ME, et al. Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse. N Engl J Med. 2011;364:1826–1836.

ADDITIONAL READING

• Chow D, Rodriguez LV. Epidemiology and prevalence of pelvic organ prolapse. Curr Opin Urol. 2013;23:293–298.

• Walters MD. Surgical correction of anterior vaginal wall prolapse. In: Walters MD, Karram MM, eds. Urogynecology and Reconstructive Pelvic Surgery, 3rd ed. Philadelphia, PA: Mosby Elsevier; 2007.

See Also (Topic, Algorithm, Media)

• Baden-Walker Staging

• Cystocele, Grading

• Cystocoele Enterocele Algorithm

• Cystocele Image

• Pelvic Organ Prolapse (Cystocele and Enterocoele)

• Pelvic Organ Prolapse Quantification System (POP-Q)

• Rectocele, Urologic Considerations

• Vaginal Mesh Erosion

• Vaginal Pessaries, Urologic Considerations

• Vaginal Prolapse

CODES

ICD9

• 618.01 Cystocele, midline

• 618.02 Cystocele, lateral

ICD10

• N81.10 Cystocele, unspecified

• N81.11 Cystocele, midline

• N81.12 Cystocele, lateral

CLINICAL/SURGICAL PEARLS

• Management of a cystocele should largely be based on patient preference and symptoms.

• Always suspect concomitant apical prolapse in the setting of stage ≥3 cystocele or a recurrent cystocele.

• Mesh grafts for cystocele repair provide a superior anatomic outcome but they are associated with higher complication rates.



If you find an error or have any questions, please email us at admin@doctorlib.org. Thank you!